EWS-FLI1 Fusion Protein Up-regulates Critical Genes in Neural Crest Development and Is Responsible for the Observed Phenotype of Ewing's Family of Tumors
Authors:
Open Access
- 1 June 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 65 (11) , 4633-4644
Abstract
The serum levels of an adrenal sex hormone, dehydroepiandrosterone sulfate (DHEA-S), are significantly more decreased in human myelomas compared with the reduction brought by physiologic decline with age. In order to clarify the effect of DHEA on myeloma cells, we investigated whether DHEA and DHEA-S could inhibit interleukin-6 (IL-6) production of bone marrow mononuclear cells and the proliferation of myeloma cells from patients with myeloma. DHEA-S and DHEA suppressed IL-6 production from a bone marrow stromal cell line, KM-102, as well as in bone marrow mononuclear cells from patients with myeloma. Furthermore, DHEA inhibited in vitro growth of the U-266 cell line and primary myeloma cells from the patients, as well as the in vivo growth of U-266 cells implanted i.p. in severe combined immunodeficiency-hIL6 transgenic mice. DHEA up-regulated the expression of peroxisome proliferator–activated receptor (PPAR), PPAR β, but not PPARγ or PPARα, and the expression of IκBα gene in myeloma cells and bone marrow stromal cells, which could explain the suppressive effect of DHEA on IL-6 production through the down-regulation of NF-κB activity. Therefore, these data revealed that DHEA-S, as well as DHEA, had a direct effect on myeloma and bone marrow stromal cells to inhibit their proliferation and IL-6 production, respectively.Keywords
All Related Versions
This publication has 46 references indexed in Scilit:
- Selective Usage of D-Type Cyclins by Ewing’s Tumors and RhabdomyosarcomasCancer Research, 2004
- TheEws/Fli-1Fusion Gene Switches the Differentiation Program of Neuroblastomas to Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorsCancer Research, 2004
- Physical and Functional Interactions among AP-2 Transcription Factors, p300/CREB-binding Protein, and CITED2Journal of Biological Chemistry, 2003
- Identification of p21 as a Direct Target of EWS-Fli1 Oncogenic Fusion ProteinJournal of Biological Chemistry, 2003
- Alteration of Mesodermal Cell Differentiation by EWS / FLI - 1 , the Oncogene Implicated in Ewing's SarcomaMolecular and Cellular Biology, 2003
- The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumorsOncogene, 2002
- Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformationOncogene, 2001
- Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Is Initiated in an Uncommitted Progenitor CellLeukemia & Lymphoma, 2001
- Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiationOncogene, 1998
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997